Emraclidine
Emraclidine (CVL-231) is a muscarinic M4 receptor positive allosteric modulator (WO2018002760, compound 11) . Emraclidine can be used for the research of neurological diseases[1].
Product Specifications
Product Name Alternative
CVL-231
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
MAChR
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/emraclidine.html
Concentration
10mM
Purity
99.82
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
O=C(CC1CN(C1)C2=CC(C(F)(F)F)=NC=C2)N3CC4=NC(C)=CC(C)=C4C3
Molecular Formula
C20H21F3N4O
Molecular Weight
390.40
Precautions
H302, H315, H319, H335
References & Citations
[1]WO2018002760
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-132812/Emraclidine-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-132812/Emraclidine-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
MAChR4
CAS Number
[2170722-84-4]
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
